IGM Biosciences (IGMS) Earnings Date & Reports

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IGMS is expected to report earnings to fall 41.53% to -35 cents per share on May 08

IGM Biosciences IGMS Stock Earnings Reports

Q1'25

Est.

$-0.35

Q4'24

Beat

by $0.13

Q3'24

Missed

by $0.21

Q2'24

Missed

by $0.75

Q1'24

Missed

by $0.02

The last earnings report on March 27 showed earnings per share of -60 cents, beating the estimate of -73 cents. With 148.33K shares outstanding, the current market capitalization sits at 82.49M.

View a ticker or compare two or three

Compare

IGMS